Trial intelligence / Profile preview

Flutiform vs Seretide in Moderate to Severe Asthma

NCT03387241Phase 3Unknown

Sponsor
Mundipharma
Start
Jun 2017
Primary completion
Dec 2019
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of fluticasone propionate + formoterol in asthma, sponsored by Mundipharma. Status: unknown.

02

Drugs

fluticasone propionate + formoterol
03

Conditions

asthma

Beyond the preview

Go deeper on NCT03387241.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03387241.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call